{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05775939",
            "orgStudyIdInfo": {
                "id": "22D.705"
            },
            "organization": {
                "fullName": "Thomas Jefferson University",
                "class": "OTHER"
            },
            "briefTitle": "PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial",
            "officialTitle": "PET Functional Imaging to Evaluate Cardiac Radiation Damage (EUCLID)",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "pet-ct-imaging-to-evaluate-cardiac-radiation-damage-in-patients-with-lung-or-esophageal-cancer-euclid-trial"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-01-20",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-01-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-01-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-02-07",
            "studyFirstSubmitQcDate": "2023-03-07",
            "studyFirstPostDateStruct": {
                "date": "2023-03-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-03-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-03-05",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Thomas Jefferson University",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This clinical trial examines positron emission tomography (PET)/computed tomography (CT) in evaluating cardiac radiation damage in patients with lung or esophageal cancer. As part of the treatment for lung or esophageal cancer, patients will undergo radiation therapy. Sometimes, during this treatment, the heart is also subjected to some radiation which could affect its function, either increasing or decreasing the function. It is not known the consequences of this change nor is it known if doctors can detect the changes associated with the radiation. Sarcoidosis FDG positron emission tomography (PET)-computed tomography (CT) scans are a common way to image cardiac inflammation and myocardial viability. This study may help doctors image the heart before, during and after radiotherapy to monitor any changes.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. To characterize radiation-related functional imaging changes in the heart using sarcoidosis fludeoxyglucose F-18 (FDG) PET-CT imaging.\n\nSECONDARY OBJECTIVES:\n\nI. 1. To evaluate the ability of imaging changes in the heart to predict for overall survival (OS).\n\nII. To evaluate the ability of imaging changes in the heart to predict for cardiac toxicity.\n\nIII. To evaluate the ability of imaging changes in the heart to predict for cardiac related death.\n\nEXPLORATORY OBJECTIVES:\n\nI. To evaluate radiation treatment planning strategies to reduce risk of cardiotoxicity.\n\nII. To determine the correlation between sarcoidosis FDG PET-CT scans and oncologic FDG PET-CT scans.\n\nOUTLINE:\n\nPatients undergo sarcoidosis FDG PET-CT of the heart before, during and, after radiotherapy.\n\nAfter completion of study treatment, patients are followed up at 12 and 24 months."
        },
        "conditionsModule": {
            "conditions": [
                "Lung Carcinoma",
                "Esophageal Carcinoma"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Diagnostic (sarcoidosis FDG PET-CT)",
                    "type": "EXPERIMENTAL",
                    "description": "Patients undergo sarcoidosis FDG PET-CT of the heart before, during and, after radiotherapy.",
                    "interventionNames": [
                        "Other: Fludeoxyglucose F-18",
                        "Procedure: Positron Emission Tomography",
                        "Procedure: Computed Tomography",
                        "Other: Questionnaire Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Fludeoxyglucose F-18",
                    "description": "Given FDG",
                    "armGroupLabels": [
                        "Diagnostic (sarcoidosis FDG PET-CT)"
                    ],
                    "otherNames": [
                        "105851-17-0",
                        "18FDG",
                        "2-Deoxy-2-(18F)Fluoro-D-Glucose",
                        "2-F18-Fluoro-2-deoxy-D-glucose",
                        "FDG",
                        "Fludeoxyglucose (18F)",
                        "fludeoxyglucose F 18",
                        "Fludeoxyglucose F18",
                        "Fluorine-18 2-Fluoro-2-deoxy-D-Glucose",
                        "Fluorodeoxyglucose F18"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Positron Emission Tomography",
                    "description": "Undergo PET-CT",
                    "armGroupLabels": [
                        "Diagnostic (sarcoidosis FDG PET-CT)"
                    ],
                    "otherNames": [
                        "Medical Imaging",
                        "PET",
                        "PET SCAN",
                        "Positron Emission Tomography Scan",
                        "proton magnetic resonance spectroscopic imaging",
                        "Positron-Emission Tomography",
                        "PT"
                    ]
                },
                {
                    "type": "PROCEDURE",
                    "name": "Computed Tomography",
                    "description": "Undergo PET-CT",
                    "armGroupLabels": [
                        "Diagnostic (sarcoidosis FDG PET-CT)"
                    ],
                    "otherNames": [
                        "CAT",
                        "CAT Scan",
                        "Computed Axial Tomography",
                        "computerized axial tomography",
                        "Computerized Tomography",
                        "CT",
                        "CT SCAN",
                        "tomography"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Ancillary studies",
                    "armGroupLabels": [
                        "Diagnostic (sarcoidosis FDG PET-CT)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in mean standardized uptake value (SUV) changes in the heart",
                    "description": "Measured by sarcoidosis fludeoxyglucose F-18 (FDG) positron emission tomography (PET)-computed tomography (CT) scans.",
                    "timeFrame": "Up to 30 months after radiotherapy"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Ability of pre- to post-radiotherapy SUV changes in the heart",
                    "description": "Measured by sarcoidosis FDG PET-CT scans.",
                    "timeFrame": "Up to 30 months after radiotherapy"
                },
                {
                    "measure": "Overall survival",
                    "description": "Survival",
                    "timeFrame": "Up to 30 months after radiotherapy"
                },
                {
                    "measure": "Cardiac toxicity",
                    "description": "Assessed using \\>= grade 2 and \\>= grade cardiac events using Common Terminology Criteria for Adverse Events (CTCAE) version 5.0.",
                    "timeFrame": "Up to 30 months after radiotherapy"
                },
                {
                    "measure": "Cardiac toxicity judged to be secondary to radiotherapy by cardiologist and radiation oncologist",
                    "description": "Judged to be secondary to radiotherapy by cardiologist and radiation oncologist",
                    "timeFrame": "Up to 30 months after radiotherapy"
                },
                {
                    "measure": "Cardiac related death",
                    "description": "Death",
                    "timeFrame": "Up to 30 months after radiotherapy"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Provide signed and dated informed consent form\n* Willing to comply with all study procedures and be available for the duration of the study\n* Male or female, aged \\>= 18\n* Life expectancy \\>= 3 months as assessed by Radiation Oncologist\n* Mean heart dose estimated by Radiation Oncologist to be \\>= 5 Gy (physics dose or biologically equivalent dose)\n* Pathologically proven (either histologic or cytologic) proven lung cancer or esophageal cancer\n* Planned radiation treatment course for management of lung or esophageal cancer \\* Both standard and hypofractionation schedules are permitted\n\nExclusion Criteria:\n\n* Contraindication for FDG PET-CT scans as assessed by the radiation oncologist or nuclear medicine radiologist\n* Palliative radiation doses defined as 20 Gy in 5 fractions",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Yevgeniy Vinogradskiy, MD",
                    "role": "CONTACT",
                    "phone": "215-955-3605",
                    "email": "yevgeniy.vinogradskiy@jefferson.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Yevgeniy Vinogradskiy",
                    "affiliation": "Thomas Jefferson University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Thomas Jefferson University Hospital",
                    "status": "RECRUITING",
                    "city": "Philadelphia",
                    "state": "Pennsylvania",
                    "zip": "19107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Yevgeniy Vinogradskiy, MD",
                            "role": "CONTACT",
                            "phone": "215-955-3605",
                            "email": "yevgeniy.vinogradskiy@jefferson.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.95233,
                        "lon": -75.16379
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000004938",
                    "term": "Esophageal Neoplasms"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000009371",
                    "term": "Neoplasms by Site"
                },
                {
                    "id": "D000005770",
                    "term": "Gastrointestinal Neoplasms"
                },
                {
                    "id": "D000004067",
                    "term": "Digestive System Neoplasms"
                },
                {
                    "id": "D000006258",
                    "term": "Head and Neck Neoplasms"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000004935",
                    "term": "Esophageal Diseases"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "asFound": "Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11172",
                    "name": "Lung Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8088",
                    "name": "Esophageal Neoplasms",
                    "asFound": "Esophageal Carcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M7256",
                    "name": "Digestive System Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M8886",
                    "name": "Gastrointestinal Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M9348",
                    "name": "Head and Neck Neoplasms",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8085",
                    "name": "Esophageal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2141",
                    "name": "Esophageal Cancer",
                    "asFound": "Esophageal Carcinoma",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC08",
                    "name": "Respiratory Tract (Lung and Bronchial) Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003847",
                    "term": "Deoxyglucose"
                },
                {
                    "id": "D000019788",
                    "term": "Fluorodeoxyglucose F18"
                }
            ],
            "ancestors": [
                {
                    "id": "D000019275",
                    "term": "Radiopharmaceuticals"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000000998",
                    "term": "Antiviral Agents"
                },
                {
                    "id": "D000000890",
                    "term": "Anti-Infective Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21686",
                    "name": "Fluorodeoxyglucose F18",
                    "asFound": "One year",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7043",
                    "name": "Deoxyglucose",
                    "asFound": "Cytomegalovirus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8587",
                    "name": "Fluorides",
                    "relevance": "LOW"
                },
                {
                    "id": "M21258",
                    "name": "Radiopharmaceuticals",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M4314",
                    "name": "Antiviral Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4214",
                    "name": "Anti-Infective Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Infe",
                    "name": "Anti-Infective Agents"
                }
            ]
        }
    },
    "hasResults": false
}